This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
NPM1 mutation reprograms leukemic transcription network via reshaping TAD topology
Leukemia Open Access 26 June 2023
-
HOXBLINC long non-coding RNA activation promotes leukemogenesis in NPM1-mutant acute myeloid leukemia
Nature Communications Open Access 29 March 2021
-
Single cell analysis of clonal architecture in acute myeloid leukaemia
Leukemia Open Access 19 December 2018
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Bacher U, Schnittger S, Haferlach T . Molecular genetics in acute myeloid leukemia. Curr Opin Oncol 2010; 22: 646–655.
Ghanem H, Tank N, Tabbara IA . Prognostic implications of genetic aberrations in acute myelogenous leukemia with normal cytogenetics. Am J Hematol 2011; 87: 69–77.
Ishikawa Y, Kiyoi H, Tsujimura A, Miyawaki S, Miyazaki Y, Kuriyama K et al. Comprehensive analysis of cooperative gene mutations between class I and class II in de novo acute myeloid leukemia. Eur J Haematol 2009; 83: 90–98.
Falini B, Mecucci C, Tiacci E, Alcalay M, Rosati R, Pasqualucci L et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med 2005; 352: 254–266.
Kottaridis PD, Gale RE, Frew ME, Harrison G, Langabeer SE, Belton AA et al. The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials. Blood 2001; 98: 1752–1759.
Gale RE, Green C, Allen C, Mead AJ, Burnett AK, Hills RK et al. The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia. Blood 2008; 111: 2776–2784.
Gruszka AM, Lavorgna S, Consalvo MI, Ottone T, Martinelli C, Cinquanta M et al. A monoclonal antibody against mutated nucleophosmin 1 for the molecular diagnosis of acute myeloid leukemias. Blood 2010; 116: 2096–2102.
Vassiliou GS, Cooper JL, Rad R, Li J, Rice S, Uren A et al. Mutant nucleophosmin and cooperating pathways drive leukemia initiation and progression in mice. Nat Genet 2011; 43: 470–475.
Lee BH, Tothova Z, Levine RL, Anderson K, Buza-Vidas N, Cullen DE et al. FLT3 mutations confer enhanced proliferation and survival properties to multipotent progenitors in a murine model of chronic myelomonocytic leukemia. Cancer Cell 2007; 12: 367–380.
Alcalay M, Tiacci E, Bergomas R, Bigerna B, Venturini E, Minardi SP et al. Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+ AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance. Blood 2005; 106: 899–902.
Acknowledgements
MM has a fellowship from Fondazione Umberto Veronesi (FUV). This work was supported by grants from Associazione Italiana Ricerca sul Cancro (AIRC) and Ministero della Salute to EC and PGP. We thank Roberta Aina for editing the manuscript.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Research on animals
The corresponding authors declare that the described study conforms to all the regulations protecting animals used for research purpose. The procedures related to animal use have been communicated and have been approved by the Italian Ministry of Health.
Author contributions
MM and AC performed most of the experiments. GP and PRR performed immunohistochemistry experiments on mouse specimens. AV contributed to study design and supervised the experimental work. PGP and EC designed the study, supervised the experimental work, and wrote and critically revised the manuscript.
Supplementary Information accompanies this paper on the Leukemia website
Rights and permissions
About this article
Cite this article
Mallardo, M., Caronno, A., Pruneri, G. et al. NPMc+ and FLT3_ITD mutations cooperate in inducing acute leukaemia in a novel mouse model. Leukemia 27, 2248–2251 (2013). https://doi.org/10.1038/leu.2013.114
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2013.114
This article is cited by
-
NPM1 mutation reprograms leukemic transcription network via reshaping TAD topology
Leukemia (2023)
-
HOXBLINC long non-coding RNA activation promotes leukemogenesis in NPM1-mutant acute myeloid leukemia
Nature Communications (2021)
-
Single cell analysis of clonal architecture in acute myeloid leukaemia
Leukemia (2019)
-
PML-RARA-associated cooperating mutations belong to a transcriptional network that is deregulated in myeloid leukemias
Leukemia (2017)
-
Overexpression of FLT3-ITD driven by spi-1 results in expanded myelopoiesis with leukemic phenotype in zebrafish
Leukemia (2016)